Great Lakes Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,299
| Closed | -$316K | – | 833 |
|
|
2024
Q2 | $316K | Buy |
+1,299
| New | +$316K | ﹤0.01% | 722 |
|
|
2024
Q1 | – | Sell |
-1,406
| Closed | -$269K | – | 806 |
|
|
2023
Q4 | $269K | Sell |
1,406
-39
| -3% | -$7.47K | ﹤0.01% | 692 |
|
|
2023
Q3 | $256K | Sell |
1,445
-73
| -5% | -$12.9K | ﹤0.01% | 682 |
|
|
2023
Q2 | $288K | Buy |
+1,518
| New | +$288K | ﹤0.01% | 649 |
|
|
2021
Q2 | – | Sell |
-6,565
| Closed | -$927K | – | 706 |
|
|
2021
Q1 | $927K | Buy |
6,565
+256
| +4% | +$36.1K | 0.02% | 454 |
|
|
2020
Q4 | $820K | Buy |
6,309
+1
| +0% | +$130 | 0.01% | 441 |
|
|
2020
Q3 | $918K | Sell |
6,308
-1,462
| -19% | -$213K | 0.02% | 411 |
|
|
2020
Q2 | $1.15M | Sell |
7,770
-84
| -1% | -$12.4K | 0.03% | 385 |
|
|
2020
Q1 | $855K | Buy |
+7,854
| New | +$855K | 0.03% | 393 |
|
|
2019
Q4 | – | Sell |
-150,601
| Closed | -$12.1M | – | 558 |
|
|
2019
Q3 | $12.1M | Buy |
+150,601
| New | +$12.1M | 0.27% | 96 |
|
|
2015
Q3 | – | Sell |
-5,433
| Closed | -$651K | – | 527 |
|
|
2015
Q2 | $651K | Buy |
+5,433
| New | +$651K | 0.02% | 394 |
|